News and Trends 27 Jun 2023
Actimed Therapeutics raises £5M to advance lead program for cancer cachexia
Actimed Therapeutics Ltd, a U.K.-based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, has raised more than £5…
